You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑋俊生物科技(00660.HK)發行2100萬港元可換股債券
格隆匯 10-22 23:12

格隆匯10月22日丨瑋俊生物科技(00660.HK)發佈公吿,於2021年10月22日,公司與中國成功(為公司關連人士)訂立該認購協議,據此,中國成功有條件同意認購,而公司有條件同意發行本金總額為2100萬港元的可換股債券。

新可換股債券附帶新可換股債券的換股權,可按新可換股債券的換股價每股新可換股債券換股股份0.05港元(可予調整)轉換為新可換股債券的換股股份,以作為債務清償。

假設所有新可換股債券按新可換股債券的換股價悉數行使,則在若干換股限制的規限下可根據該認購協議而向中國成功配發及發行4.2億股新股份,其代表(i)全部已發行股份數目約25.0%;(ii)經配發新可換股債券的換股股份擴大的全部已發行股份數目約20.0%。

董事會及林清渠先生已審視及探求不同途徑清償該股東貸款及其他貸款(連同應計利息),並認為發行可換股債券是降低集團每年產生的利息開支金額、提升集團的財務狀況及削減集團的資本負債比率的最有效及合適的方法,原因在於(i)可換股債券每年2%的較低利率,將可儘量減輕集團的短期財政負擔;(ii)股東貸款及其他貸款的本金額(連同應計利息)將於換股權獲悉數行使後全數清償,毋須任何現金流出;及(iii)發行可換股債券不會對公司股權造成即時攤薄影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account